Stephan Grupp, MD
Enriched profileSection Chief, Cellular Therapy and Transplant Section; Inaugural Director, Susan S and Stephen P Kelly Center for Cancer Immunotherapy; Medical Director, Cell and Gene Therapy Laboratory; Novotny Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania · Children's Hospital of Philadelphia
Stephan Grupp is Section Chief, Cellular Therapy and Transplant Section; Inaugural Director, Susan S and Stephen P Kelly Center for Cancer Immunotherapy; Medical Director, Cell and Gene Therapy Laboratory; Novotny Professor of Pediatrics, Perelman School of Medicine, University of Pennsylvania at Children's Hospital of Philadelphia. OpenAlex indexes 804 publications with 64,125 citations (h-index 105); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory. Clarivate lists Stephan Grupp as a Highly Cited Researcher (Clinical Medicine, 2021-2025; Cross-Field, 2018-2020).
Data verified 17 Aug 2026
Overview
Updated 14 Oct 2026
Stephan Grupp, MD, is Section Chief, Cellular Therapy and Transplant Section at Children's Hospital of Philadelphia. The public record shows 804 publications with 64,125 citations (h-index 105), centered on CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Hematopoietic Stem Cell Transplantation. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 12 companies, 9 NIH-funded awards (1996–2026).
- Most recent indexed publication: 2026 · Nature biomedical engineering
- Top research focus: CAR-T cell therapy research
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 302.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Stephan Grupp MD PhD
- PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma
Sponsor: Stephan Grupp MD PhD
- Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Sponsor: Stephan Grupp MD PhD
Industry payments
Updated 14 Oct 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year202517 payments$44,441openpaymentsdata.cms.gov ↗
- Vertex Pharmaceuticals IncorporatedProgram year20252 payments$19,591openpaymentsdata.cms.gov ↗
- McKesson Sourcing Services, Inc.Program year202513 payments$12,634openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Oct 2026
9 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:
- Early Identification and Prevention of Type 1 Diabetes Using Polygenic Risk Score Screening and CAR-T-reg Therapy
Children'S Hosp of Philadelphia
FY2026$889,998R01DK145085
Congress activity
Updated 14 Oct 2026
108 congress contributions (2010–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Financial toxicity and association with treatment outcomes during pediatric CAR T therapy.
ASCO Annual Meeting
ASCO2025Co-author - Pregnancy and infant outcomes post–CD19-directed CAR-T therapy: Tisagenlecleucel (tisa-cel) and/or huCAR19 (CTL119).
ASCO Annual Meeting
ASCO2025Presenting author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Directed evolution-based discovery of ligands for in vivo restimulation of chimeric antigen receptor T cells.
Nature biomedical engineering
Article2026 - D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer.
Clinical cancer research
Article2025 - IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.
Nature communications
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/stephan-grupp-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/stephan-grupp-7b75b22a
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/GruppSteve
Mentions by others
where others cite or feature them- Instagram
instagram.com/madelinebell_childrensphila/p/C3nfw9Qs5J9
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Instagram
instagram.com/madelinebell_childrensphila/p/C_3t1Z0v-Kq
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - X / Twitter
x.com/ChildrensPhila/status/1783541496156741799
- LinkedIn
LinkedIn profile: linkedin.com/in/stephan-grupp-7b75b22a (CHOP, Director Cell Therapy and Transplant)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- Board Certified
Pediatrics (American Board of Pediatrics)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗ - Board Certified
Pediatric Hematology-Oncology (American Board of Pediatrics)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Clinical Medicine20212022202320242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
- Cross-Field201820192020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chop.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- Blood and Marrow Transplant Program
Cancer Center, Immunotherapy Program, Leukemia and Lymphoma Program, Cell and Gene Therapy Innovations (CHOP)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →chop.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →chop.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →research.chop.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jack Rychik, MD
Children's Hospital of Philadelphia
Michael Hogarty, MD
Children's Hospital of Philadelphia
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center